<DOC>
	<DOCNO>NCT02714712</DOCNO>
	<brief_summary>The scavenger receptor type B class I ( SR-BI ) receptor high-density lipoprotein ( HDL ) one entry factor hepatitis C virus ( HCV ) . The investigator aim examine association single nucleotide polymorphism ( SNPs ) SCARB1 gene , encode SR-BI , virologic response pegylated interferon-based treatment Asian chronic hepatitis C ( CHC ) patient .</brief_summary>
	<brief_title>SR-BI Antiviral Treatment Response HCV</brief_title>
	<detailed_description>1 . Purpose study : To examine impact single nucleotide polymorphism ( SNPs ) relevant SR-BI CHC patient . 2 . Study Design To enroll 400 CHC patient 3-year period 3 . Specify objective study collect extra specimen participant Collect blood sample genomic DNA examine SR-BI gene polymorphism . 4 . Expected Endpoints Treatment Sustained virologic response ( SVR ) mean undetectable serum HCV RNA level 24 week completion antiviral therapy .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>1 . Naive IFN treatment experimental antiviral immunosuppressive therapy enrollment . 2 . Serum alanine aminotransferase level , least , twice upper limit normal two occasion within previous 6 month . 1 . Positive hepatitis B surface antigen 2 . Positive human immunodeficiency virus antibody 3 . Had know history evidence autoimmune liver disease , inheritable disorder , renal insufficiency , malignancy 4 . Had history daily alcohol consumption great 20 gram active drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>